Brief: Kyongbo Pharmaceutical Terminates Supply Contract Worth $45 Mln Due To Non-Compliance With Contract Terms
07/06/2022 06:39
June 7 (Reuters) - Kyongbo Pharmaceutical Co Ltd
214390.KS :
* TERMINATES SUPPLY CONTRACT WORTH 57 BILLION WON ($45.27
million)
DUE TO NON-COMPLIANCE WITH CONTRACT TERMS
Source text for Eikon: https://bit.ly/3mi1u9w
Further company coverage: 214390.KS
($1 = 1,259.0300 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on Kyongbo Pharmaceutical
See all newsBrief: Kyongbo Pharmaceutical Q1 Operating Profit 713 Million Won, Up 489.3% From Year Earlier
Brief: Kyongbo Pharmaceutical Q3 Operating Profit 474 Million Won, Down 85% From Year Earlier
Brief: Kyongbo Pharmaceutical Q2 Operating Profit 2.4 Billion Won, Up 90% From Year Earlier
Brief: Kyongbo Pharmaceutical To Invest 85.5 Billion Won In Building Additional Factory
Brief: Kyongbo Pharmaceutical Q2 Operating Profit 1.3 Billion Won, Down 14.8% From Year Earlier